跳至主要内容
临床试验/CTRI/2022/07/044123
CTRI/2022/07/044123尚未招募未知

A Synopsis on Effectiveness of Individualized Homoeopathic medicines and Chimaphila umbellata Mother tincture in the treatment of Benign Prostatic Hyperplasia: An Open Randomized Clinical Trial

ational Institute Of Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a)Patients presenting symptoms of Benign Prostatic Hyperplasia with or without evidence of bladder outflow obstruction (AUASS more than 7) b)Patients suffering from cases of Benign Prostatic Hyperplasia diagnosed radiologically (USG-PELVIS) and ultrasonographical examination of Prostate weight more than 20g/20cc and RUV of more than 30ml c)Patients already undergoing regular therapy for BPH, provided the medications are stopped completely at least 2weeks prior study entry d)Male patients of all religions and of different socioeconomic status e)Patients with known but controlled systemic diseases f)Patients giving written consent to participate in the study

排除标准

  • a)Patients with Serum Prostate specific antigen (PSA) more than 4 nmol/mL to rule out suspected
  • prostatic malignancy
  • b)Cases suffering from uncontrolled systemic illness or life-threatening conditions.
  • c)Patient suffering from complete retention of urine for more than 24hrs.
  • d)Patient with frequent urination or retention of urine due to systemic or neurological disorder.
  • e)Patient suffering from neurogenic bladder or urethral stricture

研究者

发起方
ational Institute Of Homoeopathy

相似试验